InvAscent, a healthcare private equity firm, announced that it is investing Rs 70 crore in Murli Krishna Pharma Pvt. Ltd, a drug delivery systems (DDS) company in India that provides a range of effective solutions to optimize the delivery of pharmaceutical products. InvAscent has put Rs 70 crore ($9.25 million) in the Pune-based company, the…